CAS 52706-07-7

(R)-5,7-Dihydroxyspiro[2H-1-benzopyran-3(4H),5'(6'H)-cyclobuta[f][1,3]benzodioxol]-4-one

CAS : 52706-07-7

Formule : C₁₇H₁₂O₆

Degré de pureté : 98.0%

Masse moléculaire : 312.2736

Ref: IN-DA00DH0E

Scillascillin

CAS : 52706-07-7

Scillascillin shows promise in treating breast (MCF-7) and prostate (DU-145) cancers, IC50: 9.59 & 11.32 ug/ml.

Formule : C₁₇H₁₂O₆

Degré de pureté : 98%

Couleur et forme : Solid

Masse moléculaire : 312.27

Ref: TM-TN4963

Scillascillin

CAS : 52706-07-7

Formule : C₁₇H₁₂O₆

Degré de pureté : 95%~99%

Couleur et forme : Powder

Masse moléculaire : 312.277

Ref: BP-SBP01606

Scillascillin

CAS : 52706-07-7

Scillascillin is a cardiac glycoside, which is derived from the plant species Urginea maritima, commonly known as the sea squill. The source of Scillascillin, Urginea maritima, is a bulbous plant native to the Mediterranean region. The mode of action of Scillascillin involves inhibiting the Na⁺/K⁺-ATPase pump, leading to an increase in intracellular sodium levels. This subsequently enhances the influx of calcium ions through the sodium-calcium exchange mechanism, resulting in increased cardiac contractility.

Formule : C₁₇H₁₂O₆

Degré de pureté : Min. 95%

Masse moléculaire : 312.27 g/mol

Ref: 3D-CCA70607